Skip to main content

Table 1 Study patient characteristics

From: Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome

Total number of patients 44
Demographic
 Age, year, median (IQR) 63.5 (58.0–68.5)
 Male, n (%) 18 (40.9)
Comorbidities
 Body mass index, kg/m2, median (IQR) 34.7 (32.0–41.8)
 Current smoking, n (%) 3 (6.8%)
 Type 2 diabetes, n (%) 19 (43.2%)
 Insulin use, n (%) 6 (13.6%)
 MI, n (%) 5 (11.4%)
 Statin use, n (%) 33 (75.0%)
 Family history of MI, n (%) 22 (50.0%)
 10-year Reynolds risk score, %, median (IQR) 11.2 (4.2–19.4)
Laboratory data, median (IQR)
 Uric acid, mg/dL 7.8 (7.1–8.4)
 Total cholesterol, mg/dL 167.5 (153.0–198.0)
 Triglycerides, mg/dL 172.5 (115.0–201.5)
 HDL, mg/dL 44.0 (38.0–54.0)
 LDL, mg/dL 87.0 (76.5–116.5)
 Fasting blood glucose, mg/dL 100.5 (92.5–135.0)
 Serum creatinine, mg/dL 0.9 (0.8–1.2)
 eGFR, mL/min/1.73m2 48.5 (34.5–57.5)
 Fasting insulin, mIU/L 18.2 (14.4–21.9)
 HOMA-IR 4.8 (3.4–6.5)
 hs-CRP, mg/L 2.9 (1.1–7.4)
 Interleukin-6, pg/mL 4.5 (2.4–6.8)
 Urine microalbumin, mg/L 15.0 (7.5–43.4)
Cardiovascular function, median (IQR)
 Systolic blood pressure, mmHg 131 (123–146)
 Diastolic blood pressure, mmHg 65 (61–76)
 Rest heart rate, per minute 72 (64–78)
 Stress heart rate, per minute 94 (84–103)
 Rest myocardial blood flow, mL/min/g 0.8 (0.7–0.9)
 Stress myocardial blood flow, mL/min/g 1.7 (1.3–2.2)
 Coronary flow reserve 1.9 (1.7–2.4)
 Rest left ventricular ejection fraction, % 60.0 (52.0–67.0)
 Stress left ventricular ejection fraction, % 63.0 (54.5–70.0)
 Summed stress score 0 (0–6)
 Summed rest score 0 (0–0)
 Summed difference score 0 (0–5)
  1. IQR = interquartile range, MI = myocardial infarction, eGFR = estimated glomerular filtration rate, HDL = high-density lipoprotein, LDL = low-density lipoprotein, HOMA-IR = Homeostatic Model Assessment of Insulin Resistance (normal < 3), hs-CRP = high sensitivity C-reactive protein